Bleeding Disorders
Conference Coverage
Thalidomide offers short-term efficacy in HHT
All 29 evaluable patients responded to thalidomide, with 4 achieving a complete response. Unfortunately, 11 patients relapsed at a median of 43...
Conference Coverage
Eltrombopag reduces bleeding in children with chronic immune thrombocytopenia
Key clinical point: Eltrombopag may soon be a treatment option for children with chronic immune thrombocytopenia. Major finding: Platelet response...
News
New approach for treating PNH
Investigators have identified a novel strategy for treating paroxysmal nocturnal hemoglobinuria (PNH), according to a paper published in Blood....
News
Platelets, iron may affect stroke risk in HHT patients
Credit: Andre E.X.
Clinical Review
von Willebrand Disease: Approach to Diagnosis and Management
News
Inhibitor strengthens RBCs in PNH
Credit: NHLBI The apoptosis inhibitor aurin tricarboxylic acid (ATA) is active against paroxysmal nocturnal hemoglobinemia (PNH), according to...
News
Eculizumab decreases risk of thrombosis in PNH
Peter Hillmen, MD, of the Leeds Teaching Hospitals NHS Trust, reported the results of the study at the 12th Congress of the European Hematology...